Learn if You Have a Claim Against Eli Lilly & Co.

FDA, Eli Lilly Updates Labeling for Strattera To Include Suicidal Thinking in Children The FDA directed Eli Lilly and Company, the manufacturer of Strattera (atomoxetine), to revise the prescribing information to include a boxed warning and additional warning statements that alert health care providers of an increased risk of suicidal thinking in children and adolescents being treated with this medication. FDA also informed Lilly that a Patient Medication Guide (MedGuide) should be provided to patients when Strattera is dispensed. The MedGuide advises patients of the risks associated with and precautions that can be taken when Strattera is dispensed.
Claimant Information

Are you submitting this information on behalf of yourself?	Yes No
Are you submitting this information on behalf of an adolescent child?	Yes No
If yes, please provide: Name of Child
Age of Child
Relationship to Child
Strattera Use

Was the Strattera user an adolescent at the time of use?	Yes No
Date you began taking Strattera:
Date you stopped taking Strattera:
Medical Information

Did the Strattera user commit or attempt suicide?	Yes No
If yes please explain:
Date of suicide or attempt:
City in which suicide or attempt occurred:
State in which suicide or attempt occurred:
Did the Strattera user attempt suicide prior to the use of the Strattera?	Yes No
If yes, please explain:
Are you presently covered by health insurance?	Yes No
Have you previously retained an attorney to represent you in this matter?	Yes No

Personal Information

First Name

Last Name

Street / Apt /

City, State Zip

Home Phone & Evening Phone (Same) . . & . .

E-Mail Address

Confirm E-Mail

Date Issue/Problem

Terms & Conditions
I acknowledge that I have read and understand and agree to the following legal policies.

Certain features of Lawcash.com require a login - please simply choose a password to continue.

Password

Confirm Password

I'd like to become a Lawcash.com member, receive a free class action ebook, and free class action and recall alerts. Billions of dollars are available each year and I'd like to claim my fair share from bad corporations.

Submit

Other Drugs / Medical Cases of Interest

Express Scripts Stock Crashes on News of NY AG Investigations

Several class actions have been filed against pharmacy benefit management company Express Scripts, Inc., (Nasdaq:ESRX) and certain of its officers and directors by stockholders who purchased the company's common stock between October 29, 2003, and August 3, 2004. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities.

Light Cigarette Action Filed Against Tobacco Industry in New York

A class action has been filed against major tobacco companies on behalf of current and former light cigarette smokers in New York. The action alleges that the companies violated the federal Racketeer Influenced and Corrupt Organizations Act when they advertised light cigarettes as being less harmful than regular cigarettes despite knowing they deliver comparable amounts of tar and nicotine.

Yale New Haven Hospital Sued for Not Providing Free Care

A class action has been filed against Yale New Haven Hospitals for failing to provide healthcare services to Connecticut residents regardless of their ability to pay. The lawsuit alleges that Yale has an obligation to provide free or low cost healthcare services because it operates as a non-profit organization and is exempt from federal, state and local taxes.

Company Hid Serious Problems with Aorta Graft Product

Kahn Gauthier Swick is investigating possible legal actions against EndoVascular Technologies, Inc., a wholly-owned subsidiary of medical device manufacturer Guidant Corporation, on behalf of persons who were implanted with EndoVascular's Ancure Endograft System, which is used to repair abdominal aorta aneurysms.

SmithKline Beecham Misled US Doctors Regarding Paxil Use for Children

A class action has been filed against pharmaceutical company SmithKline Beecham Corporation on behalf of all persons who purchased the antidepressant Paxil or Paxil CR (paroxatine) for children under the age of 18 between November 19, 1998, and the present. The suit alleges that the company committed fraud by suppressing clinical study data that indicated Paxil was ineffective for children.

AL and GA United Wisconsin Life Insurance Company Healthcare Policyholders Settle With Company

The parties have reached a tentative settlement in a class action filed against United Wisconsin Life Insurance Company, American Medical Security, Inc., Prescription for Good Health Trust and AmSouth Bank on behalf of all persons in Alabama and Georgia who purchased a certificate of medical insurance from United Wisconsin. The legal notice describing the class action does not state the deadline for filing claims under the settlement. Persons eligible to take part in the settlement should contact the settlement administrator for more information.